| BRD4 sustains melanoma proliferation and represents a new target for epigenetic therapy MF Segura, B Fontanals-Cirera, A Gaziel-Sovran, MV Guijarro, ... Cancer research 73 (20), 6264-6276, 2013 | 251 | 2013 |
| miR-99a reveals two novel oncogenic proteins E2F2 and EMR2 and represses stemness in lung cancer A Feliciano, Y Garcia-Mayea, L Jubierre, C Mir, M Hummel, J Castellvi, ... Cell Death & Disease 8 (10), e3141-e3141, 2017 | 90 | 2017 |
| BRG1/SMARCA4 is essential for neuroblastoma cell viability through modulation of cell death and survival pathways L Jubierre, A Soriano, L Planells-Ferrer, L París-Coderch, SP Tenbaum, ... Oncogene 35 (39), 5179-5190, 2016 | 86 | 2016 |
| microRNAs as pharmacological targets in cancer A Soriano, L Jubierre, A Almazan-Moga, C Molist, J Roma, JS De Toledo, ... Pharmacological research 75, 3-14, 2013 | 72 | 2013 |
| ATRX in-frame fusion neuroblastoma is sensitive to EZH2 inhibition via modulation of neuronal gene signatures ZA Qadeer, D Valle-Garcia, D Hasson, Z Sun, A Cook, C Nguyen, ... Cancer Cell 36 (5), 512-527. e9, 2019 | 65 | 2019 |
| Targeting of epigenetic regulators in neuroblastoma L Jubierre, C Jiménez, E Rovira, A Soriano, C Sábado, L Gros, A Llort, ... Experimental & molecular medicine 50 (4), 1-12, 2018 | 46 | 2018 |
| MicroRNA-497 impairs the growth of chemoresistant neuroblastoma cells by targeting cell cycle, survival and vascular permeability genes A Soriano, L París-Coderch, L Jubierre, A Martínez, X Zhou, O Piskareva, ... Oncotarget 7 (8), 9271, 2016 | 41 | 2016 |
| Krüppel-like factor 4 (KLF4) regulates the miR-183~ 96~ 182 cluster under physiologic and pathologic conditions MF Segura, L Jubierre, SD Li, A Soriano, L Koetz, A Gaziel-Sovran, ... Oncotarget 8 (16), 26298, 2017 | 15 | 2017 |
| Optimization of rhabdomyosarcoma disseminated disease assessment by flow cytometry A Almazán‐Moga, J Roma, C Molist, I Vidal, L Jubierre, A Soriano, ... Cytometry Part A 85 (12), 1020-1029, 2014 | 11 | 2014 |
| Neuronal Differentiation-Related Epigenetic Regulator ZRF1 Has Independent Prognostic Value in Neuroblastoma but Is Functionally Dispensable In Vitro C Jiménez, R Antonelli, M Masanas, A Soriano, L Devis-Jauregui, ... Cancers 13 (19), 4845, 2021 | | 2021 |
| Neuronal Differentiation-Related Epigenetic Regulator ZRF1 Has Independent Prognostic Value in Neuroblastoma but Is Functionally Dispensable In Vitro. Cancers 2021, 13, 4845 C Jiménez, R Antonelli, M Masanas, A Soriano, L Devis-Jauregui, ... s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2021 | | 2021 |
| GENE-05. ATRX IN-FRAME FUSION NEUROBLASTOMA IS SENSITIVE TO EZH2 INHIBITION VIA MODULATION OF NEURONAL GENE SIGNATURES Z Qadeer, D Valle-Garcia, D Hasson, A Soriano, A Ma, L Griffiths, ... Neuro-Oncology 21 (Suppl 2), ii81, 2019 | | 2019 |
| The miR-15 family members are therapeutic candidates to treat chemoresistant neuroblastomas A Soriano, L Paris-Coderch, L Jubierre, A Almazán-Moga, C Molist, ... Cancer Research 74 (19_Supplement), 4380-4380, 2014 | | 2014 |
| ITGA9 (integrin, alpha 9) C Molist, A Almazán-Moga, I Vidal, A Soriano, L Jubierre, MF Segura, ... | | 2014 |
